2016 Newsletter Archive

January 2016

Alzheimer’s Advocate vol. 94

Save-the-Date: ACT-AD Webinar on Personalized Medicine

FDA Workshop to Gather Perspectives on Genetic Testing

ACT-AD a Media Partner for 10th Annual Drug Discovery Conference

How Will Alzheimer’s Disease Impact China?

ACT-AD Welcomes New Member, APOE4.Info, Inc.

Alzheimer’s Disease-Related Dementias 2016 Summit Set for March 29-30

Experts Say Urine Test Could Potentially Predict AD

February 2016

Alzheimer’s Advocate vol. 95

Don’t Miss ACT-AD’s Webinar on Personalized Medicine

New Study Suggests Incidence of Dementia May Be Declining

Experts ID Part of the Brain That May Be First Impacted by Alzheimer’s Disease Onset

Bill to Create Alzheimer’s Stamp Introduced in House

March 2016

Alzheimer’s Advocate vol. 96

Save the Date for ACT-AD’s Ninth Annual FDA/AD Allies Meeting/November 16

ACT-AD Submits Letter Calling for Increased Funding for FDA

ACT-AD’s Bens to Speak at CDER Event on March 31

AHRQ Releases New Report on Dementia and Nonpharmacologic Interventions

Researchers Say PET Scans Can Track Progressive Stages of AD for the First Time

Upcoming PBS Special Focuses on Alzheimer’s Disease

FDA Issues Draft Guidance Request on Neurological Devices

NIH Launches Consortium to Study Vascular Links to AD

CIBR Medical Technology Showcase Set for April 12

New Dementia Care Plan Tool Launches

New Film Looks at a Condition Called PseudoBulbar Affect

April 2016

Alzheimer’s Advocate vol. 97

Webinar on Personalized Medicine and Alzheimer’s Disease Now Available

Save the Date for ACT-AD’s Ninth Annual FDA/AD Allies Meeting/November 16

Researchers Explore Role of Microglia in Alzheimer’s Disease

LEAD Coalition Looking for Communications & Advocacy Director

ICYMI: PBS Special Focuses on Alzheimer’s Disease


May 2016

Alzheimer’s Advocate vol. 98

Senate Committee Acts on Fiscal Year 2017 FDA Appropriations

Prospects Are Promising for Innovation Legislation

Save the Date for ACT-AD’s Ninth Annual FDA/AD Allies Meeting/November 16

Could Tau Proteins Offer Early Warning of Memory Loss?

Finding Could Provide New Insights about Alzheimer’s Disease

June 2016

Alzheimer’s Advocate vol. 99

ACT-AD Webinar on Clinical Meaningfulness/July 19/10 a.m. ET

ACT-AD’s Bens Speaks at Precision Medicine Briefing

New Study Results Offer Hope for Reversing Memory Loss Caused by Alzheimer’s Disease

Capitol Hill Briefing on Research at the NIA

Researchers Gain Insights into Amyloid Beta Proteins

Save the Date for ACT-AD’s Ninth Annual FDA/AD Allies Meeting/November 16

July 2016

Alzheimer’s Advocate vol. 100

ICYMI: ACT-AD Webinar on Clinical Meaningfulness Available Online

FDA Releases Commitment Letter for PDUFA Reauthorization

Recent Study Says Specialized Brain Training May Forestall Alzheimer’s Disease

Get Highlights from AAIC Conference

Save the Date for ACT-AD’s Ninth Annual FDA/AD Allies Meeting/November 16

August 2016

Alzheimer’s Advocate vol. 101

ACT-AD Welcomes New Science Advisory Board Member

National Survey Results Highlight Dementia Priorities

Study Finds Dementia Patients with Low Continuity of Care Have Higher Health Costs

ACT-AD’s Bens Presents at August PDUFA VI Public Meeting

NIH Creates Bypass Budget to Meet National Alzheimer’s Plan

Save the Date for ACT-AD’s Ninth Annual FDA/AD Allies Meeting/November 16

September 2016

Alzheimer’s Advocate vol. 102

NIH Award Expands Landmark Alzheimer’s Biomarker Study

Save the Date for ACT-AD’s Ninth Annual FDA/AD Allies Meeting/November 16

What’s New at Anavex/An Update

ACT-AD Executive Director to Speak at BIO’s Patient & Health Advocacy Summit

Alzheimer’s Foundation of America Offers Free Webinar on Dementia Related Topics

The 13th International Conference on Alzheimer’s and Parkinson’s Disease Registration Deadline/December 14